Answers are grounded in this paper and cite their sources.
BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infection in young children and an important healthcare-associated infection (HAI) in paediatric settings. This study aimed to describe the epidemiology and clinical impact of RSV-HAI and assess the potential feasibility of prospective surveillance. METHODS: Single-centre surveillance study using retrospective and prospective weekly case ascertainment over four years (2018-2020, and 2024). RSV positive children with symptom onset greater than 72 h post presentation were eligible and followed for two weeks. Surveillance by a specialist IPC nurse was supported through a digital report in the electronic medical record system. Data were reported on RSV-HAI per 1000 occupied bed days, child characteristics, and clinical outcomes. Surveillance feasibility indicators included surveillance workload and screening yield. RESULTS: A total of 79 children with RSV-HAI were identified with an overall rate of 0.22 cases per 1000 occupied bed days. The median age of children was 2.1 years (interquartile range 0.4-6.8) and most had a medical comorbidity (65/76, 85.5%). One third of children received antibiotics to treat acute lower respiratory infection (26/79, 32.9%) and 11.4% (9/79) were new admissions to the intensive care unit. The overall screening yield was 42.9% (79/184 screened records), and surveillance screening was completed within 15 min in most surveillance weeks (175/199 weeks, 87.9%). CONCLUSION: RSV is an important and potentially preventable HAI which is highly relevant to paediatric hospital care. This pilot study demonstrates a potentially feasible surveillance approach which could support IPC program implementation.
No takes yet. Share an insight, caveat, or question.
Saravanos et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: